RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells
2019-01-01 Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells
2011-01-01 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
B-cell acute lymphoblastic leukemia (B-ALL) in CLL patients treated with lenalidomide
2018-01-01 Fuerstenau, Moritz; Fink, Anna-Maria; Herling, Carmen; Maurer, Christian; Kutsch, Nadine; De La Serna, Javier; Coscia, Marta; Crespo, Marta; Bosch, Francesc; Noesslinger, Thomas; Ghia, Paolo; Kater, Arnon P.; Ritgen, Matthias; Schilhabel, Anke; Stilgenbauer, Stephan; Tausch, Eugen; Fischer, Kirsten; Hallek, Michael J.; Eichhorst, Barbara
Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial
2011-01-01 A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL
2010-01-01 A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo
BRAF and BIRC3 Mutations Stratify a Poor Prognostic Subgroup in FCR Treated Chronic Lymphocytic Leukemia
2017-01-01 Diop, F; Moia, R; Favini, C; Spaccarotella, E; De Paoli, L; Bruscaggin, A; Spina, V; Cerri, M; Deambrogi, C; Kodipad, AA; Favini, S; Sagiraju, S; Jabangwe, C; Mauro, FR; Del Giudice, I; Forconi, F; Cortelezzi, A; Zaja, F; Visco, C; Chiarenza, A; Rigolin, GM; Marasca, R; Coscia, M; Perbellini, O; Tedeschi, A; Laurenti, L; Motta, M; Del Poeta, G; Cuneo, A; Gattei, V; Foa, R; Gaidano, G; Rossi, D
BTK and PLCG2 mutations in patients with Chronic Lymphocytic Leukemia relapsing on Ibrutinib: a European Research Initiative on CLL (ERIC) study based on real-world evidence
2020-01-01 L Scarfò, S Bonfiglio, L A Sutton, V Ljungstrom, T Pandzic, D Cortese, G Gaidano, L Trentin, L Bonello, G Reda, P Panayiotidis, F Forconi, N Stavroyianni, C Bödör, C Tam, S Iyengar, A Österborg, M Coscia, L Ysebaert, O Jaksic, I Ringshausen, S Mulligan, A Tedeschi, V Strugov, Z Davis, C Pavlovsky, R Marasca, A Capasso, P Ranghetti, K Stamatopoulos, R Rosenquist, P Ghia
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: a multicentric italian survey
2012-01-01 D'Arena G; Laurenti L; Del Poeta G; Grossi A; Coscia M; Mometto G; Chiarenza A; Selleri C; Vigliotti ML; Pozzato G; Nunziata G; La Sala A; Villa MR; Simeon V; Deaglio S; De Feo V; Musto P
Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis
2009-01-01 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Efficacy and Safety of Bendamustine and Rituximab As First Salvage Treatment in Chronic Lymphocytic Leukemia: Results of the Gimema-Eric LLC1315 Study
2017-01-01 Cuneo, A; Rigolin, GM; Piciocchi, A; Moreno, C; Billio, A; Cortelezzi, A; Galieni, P; Laurenti, L; Mauro, FR; Molica, S; Gentile, M; Montillo, M; Trentin, L; Perez, AM; Coscia, M; Musuraca, G; Farina, L; Rivas-Delgado, A; Orlandi, EM; Ciolli, S; Visco, C; Pizzuti, M; Marasca, R; Marchetti, M; Re, F; Chiarenza, GA; Meneghini, V; Ilariucci, F; Gaidano, G; Vignetti, M; De la Serna, J; Foa, R; Follows, GA; Ghia, P
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells | 2019 | Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta | |
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells | 2011 | M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia | |
B-cell acute lymphoblastic leukemia (B-ALL) in CLL patients treated with lenalidomide | 2018 | Fuerstenau, Moritz; Fink, Anna-Maria; Herling, Carmen; Maurer, Christian; Kutsch, Nadine; De La Serna, Javier; Coscia, Marta; Crespo, Marta; Bosch, Francesc; Noesslinger, Thomas; Ghia, Paolo; Kater, Arnon P.; Ritgen, Matthias; Schilhabel, Anke; Stilgenbauer, Stephan; Tausch, Eugen; Fischer, Kirsten; Hallek, Michael J.; Eichhorst, Barbara | |
Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial | 2011 | A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo | |
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL | 2010 | A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo | |
BRAF and BIRC3 Mutations Stratify a Poor Prognostic Subgroup in FCR Treated Chronic Lymphocytic Leukemia | 2017 | Diop, F; Moia, R; Favini, C; Spaccarotella, E; De Paoli, L; Bruscaggin, A; Spina, V; Cerri, M; Deambrogi, C; Kodipad, AA; Favini, S; Sagiraju, S; Jabangwe, C; Mauro, FR; Del Giudice, I; Forconi, F; Cortelezzi, A; Zaja, F; Visco, C; Chiarenza, A; Rigolin, GM; Marasca, R; Coscia, M; Perbellini, O; Tedeschi, A; Laurenti, L; Motta, M; Del Poeta, G; Cuneo, A; Gattei, V; Foa, R; Gaidano, G; Rossi, D | |
BTK and PLCG2 mutations in patients with Chronic Lymphocytic Leukemia relapsing on Ibrutinib: a European Research Initiative on CLL (ERIC) study based on real-world evidence | 2020 | L Scarfò, S Bonfiglio, L A Sutton, V Ljungstrom, T Pandzic, D Cortese, G Gaidano, L Trentin, L Bonello, G Reda, P Panayiotidis, F Forconi, N Stavroyianni, C Bödör, C Tam, S Iyengar, A Österborg, M Coscia, L Ysebaert, O Jaksic, I Ringshausen, S Mulligan, A Tedeschi, V Strugov, Z Davis, C Pavlovsky, R Marasca, A Capasso, P Ranghetti, K Stamatopoulos, R Rosenquist, P Ghia | |
Complementary and alternative medicine use in patients with chronic lymphocytic leukemia: a multicentric italian survey | 2012 | D'Arena G; Laurenti L; Del Poeta G; Grossi A; Coscia M; Mometto G; Chiarenza A; Selleri C; Vigliotti ML; Pozzato G; Nunziata G; La Sala A; Villa MR; Simeon V; Deaglio S; De Feo V; Musto P | |
Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis | 2009 | Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia | |
Efficacy and Safety of Bendamustine and Rituximab As First Salvage Treatment in Chronic Lymphocytic Leukemia: Results of the Gimema-Eric LLC1315 Study | 2017 | Cuneo, A; Rigolin, GM; Piciocchi, A; Moreno, C; Billio, A; Cortelezzi, A; Galieni, P; Laurenti, L; Mauro, FR; Molica, S; Gentile, M; Montillo, M; Trentin, L; Perez, AM; Coscia, M; Musuraca, G; Farina, L; Rivas-Delgado, A; Orlandi, EM; Ciolli, S; Visco, C; Pizzuti, M; Marasca, R; Marchetti, M; Re, F; Chiarenza, GA; Meneghini, V; Ilariucci, F; Gaidano, G; Vignetti, M; De la Serna, J; Foa, R; Follows, GA; Ghia, P |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 04-CONTRIBUTO IN ATTI DI CONVEGNO 75
- 04-CONTRIBUTO IN ATTI DI CONVEGNO... 75
Data di pubblicazione
- 2010 - 2020 70
- 2008 - 2009 5
Rivista
- HAEMATOLOGICA 29
- BLOOD 24
- CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 6
- HAEMATOLOGICA 4
- HEMASPHERE 3
- LEUKEMIA & LYMPHOMA 3
- CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 2
- ANNALS OF ONCOLOGY 1
- CANCER RESEARCH 1
- FRONTIERS IN IMMUNOLOGY 1
Keyword
- Hematology 6
- immunology 5
- CLL 1
- Immunology 1
- LDH 1
- trisomy 12 1
Lingua
- eng 75
Accesso al fulltext
- no fulltext 74
- open 1